Sharma, Y.; Parihar, A.; Arya, N.; Kanwar, J.; Munisamy, M.; Katare-Pandey, M.; Tandon, A.; Rao, M.; Das, S.; Shrivastava, A.;
et al. Ferroptosis-Based Nanotherapeutic Strategies to Overcome Temozolomide Resistance in Glioblastoma: A Systematic Review and Meta-Analysis. Curr. Oncol. 2026, 33, 194.
https://doi.org/10.3390/curroncol33040194
AMA Style
Sharma Y, Parihar A, Arya N, Kanwar J, Munisamy M, Katare-Pandey M, Tandon A, Rao M, Das S, Shrivastava A,
et al. Ferroptosis-Based Nanotherapeutic Strategies to Overcome Temozolomide Resistance in Glioblastoma: A Systematic Review and Meta-Analysis. Current Oncology. 2026; 33(4):194.
https://doi.org/10.3390/curroncol33040194
Chicago/Turabian Style
Sharma, Yashaswi, Arpana Parihar, Neha Arya, Jagat Kanwar, Murali Munisamy, Megha Katare-Pandey, Ashwani Tandon, Mahadev Rao, Saikat Das, Adesh Shrivastava,
and et al. 2026. "Ferroptosis-Based Nanotherapeutic Strategies to Overcome Temozolomide Resistance in Glioblastoma: A Systematic Review and Meta-Analysis" Current Oncology 33, no. 4: 194.
https://doi.org/10.3390/curroncol33040194
APA Style
Sharma, Y., Parihar, A., Arya, N., Kanwar, J., Munisamy, M., Katare-Pandey, M., Tandon, A., Rao, M., Das, S., Shrivastava, A., Chowdhary, R., Agrawal, A., & Kanwar, R. K.
(2026). Ferroptosis-Based Nanotherapeutic Strategies to Overcome Temozolomide Resistance in Glioblastoma: A Systematic Review and Meta-Analysis. Current Oncology, 33(4), 194.
https://doi.org/10.3390/curroncol33040194
